SG11201506713TA - 2-acylaminothiazole derivative and salt thereof - Google Patents
2-acylaminothiazole derivative and salt thereofInfo
- Publication number
- SG11201506713TA SG11201506713TA SG11201506713TA SG11201506713TA SG11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA
- Authority
- SG
- Singapore
- Prior art keywords
- salt
- acylaminothiazole derivative
- acylaminothiazole
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013039964 | 2013-02-28 | ||
PCT/JP2014/054803 WO2014133056A1 (ja) | 2013-02-28 | 2014-02-27 | 2-アシルアミノチアゾール誘導体またはその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201506713TA true SG11201506713TA (en) | 2015-09-29 |
Family
ID=51428316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506713TA SG11201506713TA (en) | 2013-02-28 | 2014-02-27 | 2-acylaminothiazole derivative and salt thereof |
Country Status (24)
Country | Link |
---|---|
US (1) | US9562044B2 (ru) |
EP (1) | EP2963036B1 (ru) |
JP (1) | JP6183451B2 (ru) |
KR (1) | KR102164821B1 (ru) |
CN (1) | CN105008353B (ru) |
AR (1) | AR094921A1 (ru) |
AU (1) | AU2014221726B2 (ru) |
BR (1) | BR112015020963B1 (ru) |
CA (1) | CA2902302C (ru) |
EA (1) | EA027179B1 (ru) |
ES (1) | ES2748402T3 (ru) |
HK (1) | HK1214255A1 (ru) |
IL (1) | IL240764A0 (ru) |
MX (1) | MX368539B (ru) |
MY (1) | MY190361A (ru) |
PH (1) | PH12015501899B1 (ru) |
PL (1) | PL2963036T3 (ru) |
PT (1) | PT2963036T (ru) |
SA (1) | SA515360956B1 (ru) |
SG (1) | SG11201506713TA (ru) |
TW (1) | TWI647227B (ru) |
UA (1) | UA118445C2 (ru) |
WO (1) | WO2014133056A1 (ru) |
ZA (1) | ZA201506296B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015182686A1 (ja) * | 2014-05-28 | 2015-12-03 | アステラス製薬株式会社 | ピリジン誘導体 |
SG10202000463YA (en) | 2014-06-06 | 2020-02-27 | Astellas Pharma Inc | 2-acylaminothiazole derivative or salt thereof |
KR20170042608A (ko) | 2014-08-26 | 2017-04-19 | 아스텔라스세이야쿠 가부시키가이샤 | 2-아미노티아졸 유도체 또는 그의 염 |
EP3228616B1 (en) * | 2014-12-05 | 2019-10-16 | Astellas Pharma Inc. | Pyridine derivatives |
AR102849A1 (es) * | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
CN107530342A (zh) * | 2015-04-28 | 2018-01-02 | 安斯泰来制药有限公司 | 口服给药用医药组合物 |
WO2016183676A1 (en) * | 2015-05-20 | 2016-11-24 | Kent Imaging | Automatic compensation for the light attenuation due to epidermal melanin in skin images |
RU2709496C1 (ru) * | 2019-08-01 | 2019-12-18 | Марат Феликсович Фазылов | Способ получения аватромбопага |
JP2023529884A (ja) * | 2020-06-09 | 2023-07-12 | アニマ バイオテック インコーポレイテッド | コラーゲン1翻訳阻害剤及びその使用方法 |
EP3967311A1 (en) | 2020-09-11 | 2022-03-16 | Astellas Pharma Inc. | Compounds for use in the treatment of dry mouth |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101010905B1 (ko) | 2002-01-18 | 2011-01-25 | 아스텔라스세이야쿠 가부시키가이샤 | 2-아실아미노티아졸 유도체 또는 그 염 |
AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
CN100445281C (zh) * | 2003-05-02 | 2008-12-24 | 诺瓦提斯公司 | 与毒蕈碱性m3受体结合的奎宁环衍生物 |
EP1647553A4 (en) * | 2003-07-17 | 2008-12-31 | Astellas Pharma Inc | 2-ACYLAMINOTHIAZOL DERIVATIVE OR SALT THEREOF |
JP4774995B2 (ja) * | 2005-01-12 | 2011-09-21 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体を有効成分とする医薬組成物 |
JP4665769B2 (ja) | 2005-01-12 | 2011-04-06 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体の製造法 |
US8791136B2 (en) | 2010-07-29 | 2014-07-29 | Rigel Pharmaceuticals, Inc. | Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same |
-
2014
- 2014-02-26 TW TW103106494A patent/TWI647227B/zh not_active IP Right Cessation
- 2014-02-27 PT PT147573778T patent/PT2963036T/pt unknown
- 2014-02-27 MY MYPI2015702844A patent/MY190361A/en unknown
- 2014-02-27 AU AU2014221726A patent/AU2014221726B2/en not_active Ceased
- 2014-02-27 KR KR1020157026269A patent/KR102164821B1/ko not_active Expired - Fee Related
- 2014-02-27 MX MX2015011202A patent/MX368539B/es active IP Right Grant
- 2014-02-27 SG SG11201506713TA patent/SG11201506713TA/en unknown
- 2014-02-27 US US14/770,648 patent/US9562044B2/en not_active Expired - Fee Related
- 2014-02-27 BR BR112015020963-7A patent/BR112015020963B1/pt not_active IP Right Cessation
- 2014-02-27 CA CA2902302A patent/CA2902302C/en not_active Expired - Fee Related
- 2014-02-27 UA UAA201508421A patent/UA118445C2/uk unknown
- 2014-02-27 EP EP14757377.8A patent/EP2963036B1/en active Active
- 2014-02-27 ES ES14757377T patent/ES2748402T3/es active Active
- 2014-02-27 JP JP2015503003A patent/JP6183451B2/ja not_active Expired - Fee Related
- 2014-02-27 CN CN201480010396.6A patent/CN105008353B/zh not_active Expired - Fee Related
- 2014-02-27 WO PCT/JP2014/054803 patent/WO2014133056A1/ja active Application Filing
- 2014-02-27 AR ARP140100632A patent/AR094921A1/es unknown
- 2014-02-27 EA EA201591391A patent/EA027179B1/ru not_active IP Right Cessation
- 2014-02-27 PL PL14757377T patent/PL2963036T3/pl unknown
-
2015
- 2015-08-23 IL IL240764A patent/IL240764A0/en active IP Right Grant
- 2015-08-27 SA SA515360956A patent/SA515360956B1/ar unknown
- 2015-08-27 PH PH12015501899A patent/PH12015501899B1/en unknown
- 2015-08-27 ZA ZA2015/06296A patent/ZA201506296B/en unknown
-
2016
- 2016-02-25 HK HK16102148.9A patent/HK1214255A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215795A1 (zh) | 鵝膏毒素衍生物 | |
IL244432B (en) | Aza-pyridone compounds and their uses | |
SG11201506100XA (en) | Pyridazinone-amides derivatives | |
GB201323008D0 (en) | Compounds and uses thereof | |
HK1214255A1 (zh) | -醯基氨基噻唑衍生物或其鹽 | |
ZA201601333B (en) | Oxoquinazolinyl-butanamide derivatives | |
IL244214A0 (en) | Thienopiperidine derivative and its use | |
GB201312318D0 (en) | Novel methods and compounds | |
SG11201605189YA (en) | Imidazopyrazinone derivatives | |
GB201307233D0 (en) | Compounds and uses thereof | |
DK3016978T3 (en) | Humane anti-ifn-alpha-antistoffer | |
DK3016977T3 (en) | Humane anti-il-32-antistoffer | |
GB201309180D0 (en) | Compounds and Their Uses | |
GB201314610D0 (en) | Compounds and their uses | |
GB201306248D0 (en) | Compounds and their uses | |
EP3009444A4 (en) | ALPHA-oxoacyl-Amino-caprolactam derivative | |
IL245452B (en) | Salts of Armachol | |
GB201320161D0 (en) | Compounds and their uses | |
GB201323005D0 (en) | Compounds and uses thereof | |
GB201301393D0 (en) | Kiddibidet and pottibidet | |
GB201304395D0 (en) | Real fit |